Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITPR3 | Q14573 | 8/20 | 1.00 |
| ▸ | ITPR2 | Q14571 | 4/20 | 0.94 |
| ▸ | ITPR1 | Q14643 | 4/20 | 0.94 |
| ▸ | INPP5A | Q14642 | 2/20 | 0.80 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.80 |
| ▸ | AKT1 | P31749 | 1/20 | 0.80 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Atrinositol SCHEMBL355653 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL888326 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL636077 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL180074 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL9489238 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL9022890 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL30474862 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL134177 | 1.00 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| Atrinositol SCHEMBL26683544 | 0.97 | ITPR3 (0.95) | ITPR3ITPR2ITPR1INPP5AINPPL1 | |
| SCHEMBL9094714 | 0.97 | ITPR3 (1.00) | ITPR3ITPR2ITPR1INPP5AINPPL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113169024-B | Vacuum system and method for depositing compound layers | 瑞士艾发科技 | 2025-03-11 | — | — | CN | claimed |
| CN-114149651-B | Low-odor, low-fiber-floating and heat-aging-resistant long glass fiber reinforced polypropylene material and preparation process thereof | 广州仕天材料科技有限公司 | 2023-11-21 | — | — | CN | claimed |
| EP-3900009-B1 | METHOD TO PRODUCE A PIEZOELECTRIC COATING AND VACUUM APPARATUS | EVATEC AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| US-12559490-B2 | Compositions and methods for modulating hair growth | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | KISBEE THERAPEUTICS INC (US) | 2025-10-16 | — | — | US | disclosed |
| EP-3987047-B1 | BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES | ELIGO BIOSCIENCE (FR) | 2025-05-07 | — | — | EP | disclosed |
| CN-113169024-B | Vacuum system and method for depositing compound layers | 瑞士艾发科技 | 2025-03-11 | — | — | CN | disclosed |
| CN-114502748-B | Bacterial delivery vehicles comprising tracer nucleic acid sequences | 艾力格生物科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-12215199-B2 | Polypropylene backbone, and nanoporous polypropylene membrane | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2025-02-04 | — | — | US | disclosed |
| US-12209302-B2 | Vacuum system and method to deposit a compound layer | EVATEC AG (CH) | 2025-01-28 | — | — | US | disclosed |
| US-12098372-B2 | Microbiome modulation of a host by delivery of DNA payloads with minimized spread | ELIGO BIOSCIENCE (FR) | 2024-09-24 | — | — | US | disclosed |
| US-20220135984-A1 | MICROBIOME MODULATION OF A HOST BY DELIVERY OF DNA PAYLOADS WITH MINIMIZED SPREAD | WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT | 2022-05-05 | — | — | US | disclosed |
| EP-3987047-A1 | BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES | Eligo Bioscience (FR) | 2022-04-27 | — | — | EP | disclosed |
| US-20220119458-A1 | CHIMERIC RECEPTOR BINDING PROTEINS RESISTANT TO PROTEOLYTIC DEGRADATION | ELIGO BIOSCIENCE (FR) | 2022-04-21 | — | — | US | disclosed |
| US-20220112247-A1 | CHIMERIC RECEPTOR BINDING PROTEINS FOR USE IN BACTERIAL DELIVERY VEHICLES | ELIGO BIOSCIENCE (FR) | 2022-04-14 | — | — | US | disclosed |
| US-11293111-B2 | Plating bronze on polymer sheets | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-04-05 | — | — | US | disclosed |
| US-20220098724-A1 | VACUUM SYSTEM AND METHOD TO DEPOSIT A COMPOUND LAYER | EVATEC AG (CH) | 2022-03-31 | — | — | US | disclosed |
| EP-3965751-A1 | PARA-AMINOHIPPURIC ACID (PAH) AS A RENAL PROTECTIVE SUBSTANCE | ITM Isotope Technologies Munich SE (DE) | 2022-03-16 | — | — | EP | disclosed |
| US-20220064223-A1 | BRANCHED RECEPTOR BINDING MULTI-SUBUNIT PROTEIN COMPLEXES FOR USE IN BACTERIAL DELIVERY VEHICLES | ELIGO BIOSCIENCE (FR) | 2022-03-03 | — | — | US | disclosed |
| US-11236133-B2 | Chimeric receptor binding proteins for use in bacterial delivery vehicles | ELIGO BIOSCIENCE (FR) | 2022-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319190-A1 | APOE LIPOPROTEIN SYSTEMS | APOB, APOL1, LDLR | ITPR3 4386/4885ITPR2 4181/4885ITPR1 4140/4885 |
| US-12559490-B2 | Compositions and methods for modulating hair growth | PC, MTCH2, MPC2 | ITPR3 4771/4885ITPR2 4679/4885ITPR1 4678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.